Suppr超能文献

作为强效抗菌剂的4-取代噻吩并[2,3-d]嘧啶:合理设计、微波辅助合成、生物学评价及分子对接研究

4-Substituted thieno[2,3-d]pyrimidines as potent antibacterial agents: Rational design, microwave-assisted synthesis, biological evaluation and molecular docking studies.

作者信息

Gill Rupinder K, Singh Harpreet, Raj Tilak, Sharma Anuradha, Singh Gagandeep, Bariwal Jitender

机构信息

Department of Pharmaceutical Chemistry, ISF College of Pharmacy, Moga, Punjab, India.

I. K. Gujral Punjab Technical University, Kapurthala, Jalandhar, Punjab, India.

出版信息

Chem Biol Drug Des. 2017 Dec;90(6):1115-1121. doi: 10.1111/cbdd.13028. Epub 2017 Jun 22.

Abstract

In an attempt to discover a new class of antibacterial agents with improved efficacy and to overcome the drug-resistant problems, some novel 4-substituted thieno[2,3-d]pyrimidines have been synthesized via microwave-assisted methodology and evaluated for their in vitro antibacterial activity against various pathogenic bacterial strains. Compounds 12b and 13c showed the promising inhibitory potencies against Staphylococcus aureus, Bacillus subtilis, Pseudomonas aeruginosa and Escherichia coli with MICs ranging from 2 to 10 μg/ml. Compound 13c was also found to be highly potent against methicillin-resistant S. aureus (MRSA) with MIC value of 4 μg/ml. Docking simulation studies have been performed to unravel the mode of action and association study indicate the binding of potent compounds with DHPS enzyme. In silico ADME studies suggest the drug-like characteristics of the potent compounds.

摘要

为了发现一类具有更高疗效的新型抗菌剂并克服耐药性问题,通过微波辅助方法合成了一些新型的4-取代噻吩并[2,3-d]嘧啶,并评估了它们对各种致病细菌菌株的体外抗菌活性。化合物12b和13c对金黄色葡萄球菌、枯草芽孢杆菌、铜绿假单胞菌和大肠杆菌显示出有前景的抑制效力,其最低抑菌浓度(MIC)范围为2至10μg/ml。还发现化合物13c对耐甲氧西林金黄色葡萄球菌(MRSA)具有高效力,MIC值为4μg/ml。进行了对接模拟研究以揭示其作用模式,关联研究表明强效化合物与二氢蝶酸合酶(DHPS)酶结合。计算机辅助的药物吸收、分布、代谢和排泄(ADME)研究表明强效化合物具有类药物特性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验